Total Payments
$4,656
2024 Payments
$1,375
Companies
23
Transactions
235
Medicare Patients
9,347
Medicare Billing
$707,260
Payment Breakdown by Category
Food & Beverage$4,656 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,656 | 235 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,179 | 56 | $0 (2024) |
| Janssen Biotech, Inc. | $703.80 | 37 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $428.43 | 31 | $0 (2024) |
| PFIZER INC. | $336.62 | 20 | $0 (2024) |
| Lilly USA, LLC | $292.27 | 15 | $0 (2024) |
| Incyte Corporation | $284.45 | 14 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $262.79 | 10 | $0 (2024) |
| Amgen Inc. | $225.20 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $224.73 | 9 | $0 (2024) |
| Dermavant Sciences, Inc. | $158.08 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,375 | 69 | ABBVIE INC. ($259.07) |
| 2023 | $1,878 | 91 | ABBVIE INC. ($438.17) |
| 2022 | $891.02 | 45 | ABBVIE INC. ($279.09) |
| 2021 | $214.17 | 13 | AbbVie Inc. ($134.55) |
| 2020 | $78.31 | 4 | AbbVie Inc. ($36.30) |
| 2019 | $14.41 | 1 | Sun Pharmaceutical Industries Inc. ($14.41) |
| 2018 | $117.97 | 7 | AbbVie, Inc. ($31.83) |
| 2017 | $86.97 | 5 | Biofrontera Inc. ($22.86) |
All Payment Transactions
235 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.18 | General |
| Category: Immunology | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.10 | General |
| Category: Immunology | ||||||
| 08/01/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.62 | General |
| Category: Immunology | ||||||
| 07/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: DERMATOLOGY | ||||||
| 07/03/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $10.47 | General |
| Category: Immunology | ||||||
| 06/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $11.30 | General |
| Category: DERMATOLOGY | ||||||
| 06/12/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: DERMATOLOGY | ||||||
| 06/10/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 06/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $37.36 | General |
| Category: Immunology | ||||||
| 06/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.40 | General |
| Category: Immunology | ||||||
| 06/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $2.29 | General |
| Category: Immunology | ||||||
| 06/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: IMMUNOLOGY | ||||||
| 05/31/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.09 | General |
| Category: IMMUNOLOGY | ||||||
| 05/28/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, ZEPBOUND | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Immunology | ||||||
| 05/28/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.19 | General |
| Category: Dermatology | ||||||
| 05/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $33.14 | General |
| Category: Inflammation | ||||||
| 05/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Immunology | ||||||
| 05/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: Immunology | ||||||
| 05/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.46 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,349 | 4,706 | $612,330 | $165,706 |
| 2022 | 22 | 2,520 | 4,996 | $716,922 | $190,949 |
| 2021 | 20 | 2,131 | 4,705 | $616,481 | $180,023 |
| 2020 | 27 | 2,347 | 4,599 | $587,726 | $170,582 |
Total Patients
9,347
Total Services
19,006
Medicare Billing
$707,260
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 500 | 689 | $155,025 | $39,318 | 25.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 451 | 598 | $89,700 | $21,911 | 24.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 237 | 281 | $64,630 | $19,301 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 175 | 222 | $71,040 | $17,131 | 24.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 47 | 53 | $36,570 | $12,050 | 33.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 180 | 180 | $49,500 | $11,556 | 23.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 368 | 2,033 | $30,495 | $9,678 | 31.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 105 | 114 | $28,500 | $8,440 | 29.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 52 | 65 | $13,000 | $7,530 | 57.9% |
| 96900 | Application of ultraviolet light to skin | Office | 2023 | 24 | 223 | $11,150 | $4,150 | 37.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 32 | 39 | $21,840 | $3,750 | 17.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 55 | 80 | $9,920 | $3,144 | 31.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $11,480 | $3,016 | 26.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 45 | 46 | $6,900 | $1,810 | 26.2% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 16 | 19 | $5,700 | $1,482 | 26.0% |
| 69100 | Biopsy of ear | Office | 2023 | 21 | 23 | $6,555 | $1,364 | 20.8% |
| Q0112 | All potassium hydroxide (koh) preparations | Office | 2023 | 13 | 13 | $325.00 | $74.23 | 22.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 495 | 726 | $163,350 | $40,519 | 24.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 297 | 371 | $85,330 | $24,834 | 29.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 445 | 615 | $92,250 | $20,943 | 22.7% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 71 | 81 | $55,890 | $17,818 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 154 | 197 | $63,040 | $15,535 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 157 | 157 | $43,175 | $10,055 | 23.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 67 | 89 | $17,800 | $9,931 | 55.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 364 | 2,068 | $31,020 | $9,876 | 31.8% |
About Dr. Erik Kokkonen, M.D
Dr. Erik Kokkonen, M.D is a Dermatology healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2012. The National Provider Identifier (NPI) number assigned to this provider is 1497019905.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erik Kokkonen, M.D has received a total of $4,656 in payments from pharmaceutical and medical device companies, with $1,375 received in 2024. These payments were reported across 235 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,656).
As a Medicare-enrolled provider, Kokkonen has provided services to 9,347 Medicare beneficiaries, totaling 19,006 services with total Medicare billing of $707,260. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Salem, OR
- Active Since 06/28/2012
- Last Updated 11/08/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1497019905
Products in Payments
- SKYRIZI (Biological) $616.74
- TREMFYA (Drug) $530.57
- RINVOQ (Biological) $431.74
- Sotyktu (Drug) $428.43
- EUCRISA (Drug) $320.96
- OPZELURA (Drug) $284.45
- TALTZ (Drug) $280.22
- DUPIXENT (Biological) $219.63
- Otezla (Drug) $213.85
- COSENTYX (Drug) $201.09
- REMICADE (Biological) $173.23
- VTAMA (Drug) $158.08
- HUMIRA (Biological) $98.70
- SPEVIGO (Drug) $89.14
- HADLIMA (Drug) $72.12
- LIBTAYO (Biological) $60.18
- ELEKTA MEDICAL LINEAR ACCELERATOR (Device) $51.59
- Odomzo (Drug) $47.22
- DUPIXENT DUPILUMAB INJECTION (Biological) $40.09
- ILUMYA (Biological) $35.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Salem
Dr. Russell Young, Md, MD
Dermatology — Payments: $10,674
Dermatology $10,674
Gary Gross, M.d, M.D
Dermatology — Payments: $10,537
Dermatology $10,537
Lacey Roybal, D.o, D.O
Dermatology — Payments: $7,933
Dermatology $7,933
Paarth Dodia, Do, DO
Dermatology — Payments: $7,518
Dermatology $7,518
Dr. Patrick Whitman, Do, DO
Dermatology — Payments: $7,329
Dermatology $7,329
Dr. Preston Chadwick, M.d, M.D
Dermatology — Payments: $6,596
Dermatology $6,596